Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 205, pseudogene (RN7SL205P) is a pseudogene in the human genome corresponding to the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP)[5][6][7]. The SRP complex is central to targeting secretory and membrane proteins to the endoplasmic reticulum in eukaryotic cells, but RN7SL205P itself does not encode a functional product—as a pseudogene, it is a non-functional genomic remnant of a once-active gene[5][6][7]. Human DNA contains hundreds of 7SL RNA pseudogenes, which are typically truncated, not transcribed, and have no direct functional protein product[5][6]. There is no evidence that RN7SL205P or related 7SL pseudogenes serve as drug targets, nor are they involved as biomarkers, or possess known disease associations or therapeutic utility[6][7]. While other pseudogenes can sometimes play a role in gene regulation as competing endogenous RNAs or by modulating microRNA binding, no such function is currently established for RN7SL205P[4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 205, pseudogene (RN7SL205P).